An integration pattern is a reusable architectural arrangement for connecting computational components and coordinating their data flows. In multimodal drug discovery, it determines how platforms combine evidence, models, and handoffs for a particular use case. section 13.2.3
A sequential pipeline separates discovery into dependent stages:
- PandaOmics integrates multi-omics data, biomedical literature, and pathway databases to rank disease targets for expert review. section 13.2.3
- Chemistry42 receives validated targets and generates drug-like molecules with multiple generative model families. section 13.2.3
- Later stages can use earlier outputs, such as targets or generated molecules, as inputs for subsequent design decisions. section 13.2.3
Target-to-molecule workflow
A platform first combines disease evidence, publication and patent novelty signals, clinical-trial history, and druggability predictions into a ranked target list. A molecule-generation stage then explores candidate compounds using generative adversarial networks, transformers, reinforcement learning, genetic algorithms, and autoencoders. section 13.2.3
